D-0211-2018 Class III Terminated
FDA drug recall D-0211-2018 was initiated by Akorn Inc on Dec 15, 2017 and is designated Class III. Reason for recall: CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer. The recall status is terminated (terminated Apr 10, 2019). Affected quantity: 4,885 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 17, 2018
- Initiation Date
- Dec 15, 2017
- Termination Date
- Apr 10, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,885 bottles
Product description
Gabapentin Oral Solution, 250 mg/5 mL (50 mg/mL) in a 470 mL amber-colored bottle, Rx Only. Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701. NDC: 50383-311-47
Reason for recall
CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.
Distribution pattern
Nationwide
Code information
Batch# 359774; Exp. 09/02/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0211-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026